1 January 2017 in Medicine
Management of pancreatic cysts is based on neoplastic-nonneoplastic discrimination. Endoscopic ultrasound (EUS) enables to differentiate neoplastic-nonneoplastic lesions and also allows fine-needle aspiration (FNA). In this study, we aim to assess feasibility and clinical relevance of cytological and biochemical analysis in differential diagnosis of cystic pancreatic lesions in patients who had undergone endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) due to pancreatic cysts. Participants were 96 patients who had undergone EUS-FNA for differential diagnosis of pancreatic cysts. Pancreatic cysts were classified as benign-mucinous, nonmucinous, and malignant according to patient history, physical examination, EUS appearance, and cystic fluid assessment. Tumor markers (CEA, CA(cancer antigens) 72.4, CA 19-9) , amylase, lipase and cytological assesment were compared between 3 different groups. Receiver-operating characteristics (ROC) curves were constructed to identify appropriate cut-off values. Fluid CEA and CA 72.4 levels for benign-mucinous and malignant cysts were significantly higher than for nonmucinous cysts (P ≤ 0.04). A cut-off CEA level of 207 ng/mL differentiated mucinous etiology with a sensitivity of 72.7%, specificity of 97.7%, and accuracy of 89.5%. The sensitivity, specificity, and accuracy of the CA 72.4 cut-off level of 3.32 ng/mL were 80%, 69.5%, and 73.6%, respectively. Cyst fluid CEA and CA 72.4 levels have a high accuracy in discriminating mucinous from nonmucinous cysts. When combined with cytology their accuracy rate increases.
1 January 2023 in Hepatology Forum
Background and Aim: Radioembolization (RE) is a one of the palliative treatments that have been used to down stage and/or increase the survival time in intermediate-advanced stages of HCC. We aimed to evaluate the clinical impact of RE and the clinical use of the albumin-bilirubin (ALBI) score as a predictor for survival in HCC patients. Materials and Methods: Fifty-nine unresectable hepatocellular carcinoma (HCC) patients were enrolled. RE was performed in 28 of them (group 1) and 31 patients were followed up in the natural course (NC) (group 2). Patients were classified according to the Child-Pugh score (only cirrhotic patients), Barcelona clinic liver cancer (BCLC) staging, and ALBI scores were also calculated. Results: All patients in Group 1 were cirrhotic and their BCLC stages were as follows: 60.7% stage B and 39.3% stage C. In Group 2, 83.9% of patients were cirrhotic and their BCLC stages were as follows: 9.7% stage B, 51.6% stage C, and 38.7% stage D. Mortality rates were 82% and 100% in Groups 1 and 2, respectively. The median overall survival (OS) was 13.5 months (95% CI: 10.4–16.6 months) and 4.5 months (95% CI: 3.5–5.5 months) in Groups 1 and 2, respectively (p=0.000). When RE was applied to patients with ALBI Grade 1 and 2, the median OS was statistically higher than in the NC group, respectively (p
1 January 2021 in Hepatology Forum
Background and Aim: This study was designed to predict the fibrosis stage with a clinical scoring system that may reduce the need for liver biopsy. Materials and Methods: The study cohort included the treatment of 430 chronic hepatitis B (CHB) and 170 chronic hepatitis C (CHC) of naive patients. The patients were divided into two groups as mild to moderate and severe fibrosis. After an index obtained in the study cohort, the index was tested in a validation cohort and compared with the FIB-4 Index. Results: The AUC of CHC index was found of 0.89 the sensitivity of 0.91 the specificity of 0.74, the positive predictive value (PPV) of 0.54 and the negative predictive value (NPV) of 0.96. The FIB-4 Index was applied to the CHC study cohort and the ATA Index Hepatitis C was found to be superior in terms of AUC (0.89–0.82), sensitivity (0.91–0.76) and NPV (0.96–0.86). The AUC of CHB Index was determined of 0.92, the sensitivity of 0.90, the specificity of 0.84, the PPV of 0.53 and the NPV of 0.98. Compared to the FIB-4 Index in CHB study cohort, the ATA Index Hepatitis B was predominant in terms of AUC (0.92–0.88), sensitivity (0.90–0.75), NPV (0.98–0.94) and PPV (0.53–0.49). Conclusion: ATA Indexes can predict the non-existence of severe fibrosis with an accuracy similar to FIB-4 Index and may reduce the need for liver biopsy.
25 December 2021 in Batı Karadeniz Tıp Dergisi
Aim: Hypervolemia is a common problem in hemodialysis (HD) patients. Because reaching to optimal dry weight (DW) is difficult. Chronic volume overload causes left ventricular hypertrophy. Therefore, risk of cardiovascular events is very high. High pulse pressure is an indicator of aortic stiffness, an independent risk factor for cardiovascular mortality. Pulse pressure has a strong correlation with systolic blood pressure and thus with myocardial infarction in hypertensive HD patients. Aim of this study is to investigate the relationship between pulse pressure (PP) and hypervolemia. Material and Methods: Seventy (28 male (40%), 42 (60%) female) chronic HD patients with an average of age 48 ± 12 were enrolled. All patients underwent HD 3 times weekly were included. Fluid status [Total Body Water (TBW), ECW and Intracellular Water (ICW) values] was assessed twice (beginning and end of the HD) in HD patients with the body composition monitor (BCM). And blood pressure was measured simultaneously. Before and after hemodialysis, the weight of the patients was measured and recorded. Results: At the beginning of HD, Extracellular Water (ECW) / body weight (BW) (%) was associated systolic blood pressure (SBP) and PP measured simultaneously (P=0.021, P=0.057 respectively). There was no association between diastolic blood pressure with hypervolemia and PP. Conclusion: If patients have hypervolemia especially in the interdialitic period, they have prolonged exposition to cardiovascular risk factors, because hypervolemia is corralated with SBP and PP as well. Both of them are strongly associated with cardiovascular events. Removal of adequate fluid to obtain optimal dry weight causes decrease of systolic and pulse pressure proportionally.
25 August 2022 in Akademik Gastroenteroloji Dergisi
Giriş ve Amaç: Rutin endoskopik değerlendirmede genellikle karşılaştığımız ve intestinal lenfanjiektazi olarak değerlendirdiğimiz duodenumun dağınık beyaz noktasal lezyonlarının çoğunlukla belirgin bir nedeni veya klinik karşılığı bilinmemektedir. Çalışmamızda dağınık beyaz noktasal lezyonların sıklığını, patolojik karşılığını ve Helicobacter pylori ile olan ilişkisini değerlendirmeyi amaçladık. Gereç ve Yöntem: İç Hastalıkları ve Gastroenteroloji Bilim Dalımız polikliniklerine başvuran ve aynı endoskopist tarafından dispeptik yakınma şikayeti ile gastroskopileri uygulanan toplam 445 hastanın endoskopi bulguları retrospektif olarak değerlendirildi. Endoskopik bulgularında dağınık beyaz noktasal lezyonlar saptanan hastaların antrum ve duodenal biyopsileri alınarak histolojik olarak incelendi. Bulgular: Tüm hastaların %60’ı kadın (n = 245) ve yaşları ortalaması 47.1 yıl idi. İncelenen endoskopik raporlarda 39 (%8.8) hastada dağınık beyaz noktasal lezyonların olduğu saptandı. Dağınık beyaz noktasal lezyonlar saptanan hastaların biyopsilerinde 10 hastada (%26.3) intestinal lenfanjiektazi, 21 hastada (%55.2) kronik nonspesifik duodenit ve 7 hastada (%18.5) Giardia enfeksiyonu saptandı. Dağınık beyaz noktasal lezyonların saptandığı hastaların yarısında (n = 19) Helicobacter pylori pozitif olarak saptandı (p = 0.695). Helicobacter pylori sıklığı patolojik olarak intestinal lenfanjiektazi saptanmış grupta da istatiksel olarak farklı bulunmadı. Sonuç: Dispeptik yakınmalar ile gelen hastaların gastroskopilerinde dağınık beyaz noktasal lezyonların sıklığı %8.8 olarak bulundu. Bu hastaların ancak dörtte birinde patoloji ile konfirme intestinal lenfanjiektazi görülmektedir. Dağınık beyaz noktasal lezyonlar ve intestinal lenfanjiektazi saptanması ile Helicobacter pylori pozitifliği arasında bir ilişki saptanmamıştır. Dispepsi, duodenal dağınık beyaz noktasal lezyonlar, Helicobacter pylori